Table 3.

Cox hazard estimates for SARS-CoV-2 infection (controlling for other immunosuppressant treatment).

Covariate	Coefficient	Standard error	P-value	Hazard Ratio	95% confidence interval HR
Age	0•13	0•05	0•006	1•14	1•04–1•25
Immune deficiency	1•05	0•45	0•02	2•87	1•18–6•94
Worsening of fever in week of infection	3•25	0•75	< 0•0001	25•79	5•94–112•01
Worsening of cough in week of infection	2•42	0•69	0•0005	11•29	2•91–43•73
Worsening of sore throat in week of infection	2•00	0•69	0•0037	7•41	1•92–28•61